ALMS
Alumis IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.79B
P/E Ratio
—
EPS
$-2.86
Beta
—
52W High
$30.60
52W Low
$2.76
50-Day MA
$26.19
200-Day MA
$11.64
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Alumis Inc
Alumis Inc. (ALMS) is an innovative leader in the development and commercialization of high-performance aluminum products, serving critical sectors such as automotive, aerospace, and construction. The company harnesses proprietary technologies to advance material science while adhering to sustainable manufacturing practices, ensuring minimal environmental impact. Focused on research and development, Alumis is strategically positioned to capitalize on emerging market opportunities and expand its diverse product portfolio. With a commitment to operational excellence and stakeholder value, Alumis aims to sustain long-term growth through continuous innovation.
Fundamentals
| Revenue (TTM) | $24.05M |
| Gross Profit (TTM) | $24.05M |
| EBITDA | $-438.41M |
| Operating Margin | -5067.00% |
| Return on Equity | -86.70% |
| Return on Assets | -73.40% |
| Revenue/Share (TTM) | $0.28 |
| Book Value | $2.88 |
| Price-to-Book | 9.87 |
| Price-to-Sales (TTM) | 116.04 |
| EV/Revenue | 112.31 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $123.14M |
| Float | $91.18M |
| % Insiders | 0.62% |
| % Institutions | 71.74% |
Analyst Ratings
Consensus ($38.40 target)
1
Strong Buy9
BuyData last updated: 4/7/2026